154 related articles for article (PubMed ID: 10796922)
21. Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Urol; 2009 Jun; 181(6):2526-32. PubMed ID: 19371895
[TBL] [Abstract][Full Text] [Related]
22. Polytomous logistic regression analysis could be applied more often in diagnostic research.
Biesheuvel CJ; Vergouwe Y; Steyerberg EW; Grobbee DE; Moons KG
J Clin Epidemiol; 2008 Feb; 61(2):125-34. PubMed ID: 18177785
[TBL] [Abstract][Full Text] [Related]
23. Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.
Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Bajorin DF; Donohue JP; Habbema JD
Br J Cancer; 1996 Nov; 74(9):1492-8. PubMed ID: 8912551
[TBL] [Abstract][Full Text] [Related]
24. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
Subramanian VS; Gilligan T; Klein EA
Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
[TBL] [Abstract][Full Text] [Related]
25. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
Aide N; Comoz F; Sevin E
J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
[No Abstract] [Full Text] [Related]
26. Growing teratoma syndrome: experience of a single institution.
Maroto P; Tabernero JM; Villavicencio H; Mesía R; Marcuello E; Solé-Balcells FJ; Sola C; Mora J; Algaba F; Pérez C; León X; López López JJ
Eur Urol; 1997; 32(3):305-9. PubMed ID: 9358218
[TBL] [Abstract][Full Text] [Related]
27. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
28. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
29. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Panicek DM; Toner GC; Heelan RT; Bosl GJ
Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
[TBL] [Abstract][Full Text] [Related]
30. Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
Fosså SD; Ous S; Lien HH; Stenwig AE
J Urol; 1989 Mar; 141(3):557-9. PubMed ID: 2918591
[TBL] [Abstract][Full Text] [Related]
31. Postchemotherapy surgery in nonseminomatous testicular tumors.
Hornák M; Ondrus D; Matoska J; Cársky S
Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Klepp O; Olsson AM; Henrikson H; Aass N; Dahl O; Stenwig AE; Persson BE; Cavallin-Ståhl E; Fosså SD; Wahlqvist L
J Clin Oncol; 1990 Mar; 8(3):509-18. PubMed ID: 1689773
[TBL] [Abstract][Full Text] [Related]
33. [Growing teratoma syndrome in metastatic germinal non-seminomatous testicular tumors].
Alcaraz A; Arango O; Talbot-Wrigth R; Gelabert A; Ayuso C; Alvarez-Vijande R; Bielsa O; Vesa J; Carretero P
Actas Urol Esp; 1990; 14(3):239-42. PubMed ID: 2239407
[TBL] [Abstract][Full Text] [Related]
34. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
Matsuzaki M; Nakano M; Komatsu H; Ohashi K
Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
[TBL] [Abstract][Full Text] [Related]
35. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
36. Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections.
Steyerberg EW; Keizer HJ; Stoter G; Habbema JD
Eur J Cancer; 1994; 30A(9):1231-9. PubMed ID: 7999405
[TBL] [Abstract][Full Text] [Related]
37. Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
Quek ML; Simma-Chiang V; Stein JP; Pinski J; Quinn DI; Skinner DG
Expert Rev Anticancer Ther; 2005 Oct; 5(5):869-74. PubMed ID: 16221056
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
39. [Growing teratoma syndrome].
Urruchi Fernández P; Cavero Rebollo O; Jiménez Mas JA; Martínez Bengoechea J; González Enguita C; Rioja Sanz LA
Actas Urol Esp; 1991; 15(2):205-8. PubMed ID: 1807117
[TBL] [Abstract][Full Text] [Related]
40. Potential therapeutic and diagnostic applications of the growth of testicular cancer in soft agar.
Foster BJ; Javadpour N; Ozols RF
Int J Cell Cloning; 1983 Apr; 1(1):2-14. PubMed ID: 6201566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
